OptimMRI is an AI-enabled medical device from RebrAIn, SAS, listed by FDA (510(k), K230150) with a decision date of 2023-07-21. Review panel: Radiology.
| FDA submission number | K230150 |
|---|---|
| Pathway | 510(k) |
| Company | RebrAIn, SAS |
| Review panel (specialty) | Radiology |
| FDA decision date | 2023-07-21 |
| Decision | Substantially Equivalent |
| Product code | QIH |
| Classification | Automated Radiological Image Processing Software |
| Device class | 2 |
| Regulation number | 892.2050 |
| Review time (calendar days) | 183 |
| Applicant country | FR |
Official FDA database record · FDA AI-enabled device list
All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.